Ad is loading...
FHTX
Price
$8.01
Change
-$0.79 (-8.98%)
Updated
Nov 15 closing price
109 days until earnings call
RLAY
Price
$5.11
Change
-$0.49 (-8.75%)
Updated
Nov 15 closing price
95 days until earnings call
Ad is loading...

FHTX vs RLAY

Header iconFHTX vs RLAY Comparison
Open Charts FHTX vs RLAYBanner chart's image
Foghorn Therapeutics
Price$8.01
Change-$0.79 (-8.98%)
Volume$240.96K
CapitalizationN/A
Relay Therapeutics
Price$5.11
Change-$0.49 (-8.75%)
Volume$1.93M
CapitalizationN/A
FHTX vs RLAY Comparison Chart
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FHTX vs. RLAY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Sell and RLAY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FHTX: $8.01 vs. RLAY: $5.11)
Brand notoriety: FHTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 140% vs. RLAY: 98%
Market capitalization -- FHTX: $445.3M vs. RLAY: $854.49M
FHTX [@Biotechnology] is valued at $445.3M. RLAY’s [@Biotechnology] market capitalization is $854.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 5 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than FHTX.

Price Growth

FHTX (@Biotechnology) experienced а -14.33% price change this week, while RLAY (@Biotechnology) price change was -17.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

FHTX is expected to report earnings on Mar 06, 2025.

RLAY is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($854M) has a higher market cap than FHTX($445M). FHTX YTD gains are higher at: 24.186 vs. RLAY (-53.633). FHTX has higher annual earnings (EBITDA): -91.63M vs. RLAY (-367.86M). RLAY has more cash in the bank: 688M vs. FHTX (285M). FHTX has less debt than RLAY: FHTX (40.9M) vs RLAY (51.1M). FHTX (35.2M) and RLAY (35.2M) have equivalent revenues.
FHTXRLAYFHTX / RLAY
Capitalization445M854M52%
EBITDA-91.63M-367.86M25%
Gain YTD24.186-53.633-45%
P/E RatioN/AN/A-
Revenue35.2M35.2M100%
Total Cash285M688M41%
Total Debt40.9M51.1M80%
TECHNICAL ANALYSIS
Technical Analysis
FHTXRLAY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSCAX27.980.22
+0.79%
Cove Street Capital Small Cap Val Instl
RLCAX9.75-0.03
-0.31%
Columbia Disciplined Value A
HIMDX28.73-0.13
-0.45%
Hennessy Cornerstone Mid Cap 30 Instl
TVLRX13.12-0.09
-0.68%
Touchstone Value R6
JEMSX30.80-0.24
-0.77%
JPMorgan Emerging Markets Equity I

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with NTLA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-8.98%
NTLA - FHTX
45%
Loosely correlated
-7.61%
RLAY - FHTX
43%
Loosely correlated
-8.84%
PRME - FHTX
40%
Loosely correlated
-6.95%
ABOS - FHTX
40%
Loosely correlated
-8.05%
CRSP - FHTX
40%
Loosely correlated
+0.85%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-8.84%
XNCR - RLAY
56%
Loosely correlated
-1.83%
BCYC - RLAY
46%
Loosely correlated
-3.50%
TVTX - RLAY
45%
Loosely correlated
-4.06%
PGEN - RLAY
45%
Loosely correlated
-7.11%
ABOS - RLAY
45%
Loosely correlated
-8.05%
More